These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29096935)

  • 21. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
    Nair AM; Goel R; Hindhumati M; Jayakanthan K; Visalakshi J; Joseph G; Danda S; Danda D
    Rheumatol Int; 2017 Oct; 37(10):1643-1649. PubMed ID: 28801814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
    Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
    Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study.
    Park EH; Lee EY; Lee YJ; Ha YJ; Yoo WH; Choi BY; Paeng JC; Suh HY; Song YW
    Rheumatol Int; 2018 Dec; 38(12):2233-2242. PubMed ID: 30229280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood Takayasu arteritis: disease course and response to therapy.
    Aeschlimann FA; Eng SWM; Sheikh S; Laxer RM; Hebert D; Noone D; Twilt M; Pagnoux C; Benseler SM; Yeung RSM
    Arthritis Res Ther; 2017 Nov; 19(1):255. PubMed ID: 29166923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.
    Maksimowicz-McKinnon K; Clark TM; Hoffman GS
    Arthritis Rheum; 2007 Mar; 56(3):1000-9. PubMed ID: 17328078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.
    Park MC; Lee SW; Park YB; Chung NS; Lee SK
    Scand J Rheumatol; 2005; 34(4):284-92. PubMed ID: 16195161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Patients with Takayasu Arteritis in Routine Practice with Indian Takayasu Clinical Activity Score.
    Alibaz-Oner F; Aydin SZ; Akar S; Aksu K; Kamali S; Yucel E; Karadag O; Ozer H; Kiraz S; Onen F; Inanc M; Keser G; Akkoc N; Direskeneli H
    J Rheumatol; 2015 Aug; 42(8):1443-7. PubMed ID: 26136490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of damage in Takayasu's arteritis.
    Kaymaz-Tahra S; Alibaz-Oner F; Direskeneli H
    Semin Arthritis Rheum; 2020 Aug; 50(4):586-591. PubMed ID: 32470706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
    Gudbrandsson B; Molberg Ø; Palm Ø
    Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients.
    Fan L; Zhang H; Cai J; Yang L; Liu B; Wei D; Yu J; Fan J; Song L; Ma W; Zhou X; Wu H; Lou Y
    Arthritis Res Ther; 2019 Jan; 21(1):31. PubMed ID: 30670069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.
    Karabacak M; Kaymaz-Tahra S; Şahin S; Yıldız M; Adroviç A; Barut K; Direskeneli H; Kasapçopur Ö; Alibaz-Öner F
    Semin Arthritis Rheum; 2021 Feb; 51(1):192-197. PubMed ID: 33383295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
    Liao H; Du J; Li F; Yang S; Qi G; Pan L
    Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
    Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
    Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.
    Dammacco F; Cirulli A; Simeone A; Leone P; Pulli R; Angiletta D; Rubini G; Di Palo A; Vacca A; Dammacco R
    Clin Exp Med; 2021 Feb; 21(1):49-62. PubMed ID: 33026580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease.
    Danda D; Goel R; Joseph G; Kumar ST; Nair A; Ravindran R; Jeyaseelan L; Merkel PA; Grayson PC
    Rheumatology (Oxford); 2021 May; 60(5):2246-2255. PubMed ID: 33179052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Certolizumab pegol in the treatment of Takayasu arteritis.
    Novikov PI; Smitienko IO; Sokolova MV; Alibaz-Oner F; Kaymaz-Tahra S; Direskeneli H; Moiseev SV
    Rheumatology (Oxford); 2018 Dec; 57(12):2101-2105. PubMed ID: 30010945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment.
    Ohigashi H; Tamura N; Ebana Y; Harigai M; Maejima Y; Ashikaga T; Isobe M
    J Cardiol; 2017 May; 69(5):774-778. PubMed ID: 27567177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
    Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
    J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.